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Abstract
Background: Recent studies have documented an increased risk of cardiovascular disease (CVD)
in persons with systolic blood pressures of 120–139 mmHg and/or diastolic blood pressures of
80–89 mmHg, classified as prehypertension in the Seventh Report of the Joint National Committee
on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. In this paper we
estimate the prevalence of prehypertension in Jamaica and evaluate the relationship between
prehypertension and other risk factors for CVD.
Methods: The study used data from participants in the Jamaica Lifestyle Survey conducted from
2000–2001. A sample of 2012 persons, 15–74 years old, completed an interviewer administered
questionnaire and had anthropometric and blood pressure measurements performed by trained
observers using standardized procedures. Fasting glucose and total cholesterol were measured
using a capillary blood sample. Analysis yielded crude, and sex-specific prevalence estimates for
prehypertension and other CVD risk factors. Odds ratios for associations of prehypertension with
CVD risk factors were obtained using logistic regression.
Results: The prevalence of prehypertension among Jamaicans was 30% (95% confidence interval
[CI] 27%–33%). Prehypertension was more common in males, 35% (CI 31%–39%), than females,
25% (CI 22%–28%). Almost 46% of participants were overweight; 19.7% were obese; 14.6% had
hypercholesterolemia; 7.2% had diabetes mellitus and 17.8% smoked cigarettes. With the
exception of cigarette smoking and low physical activity, all the CVD risk factors had significantly
higher prevalence in the prehypertensive and hypertensive groups (p for trend < 0.001) compared
to the normotensive group. Odds of obesity, overweight, high cholesterol and increased waist
circumference were significantly higher among younger prehypertensive participants (15–44 years-
old) when compared to normotensive young participants, but not among those 45–74 years-old.
Among men, being prehypertensive increased the odds of having >/=3 CVD risk factors versus no
risk factors almost three-fold (odds ratio [OR] 2.8 [CI 1.1–7.2]) while among women the odds of
>/=3 CVD risk factors was increased two-fold (OR 2.0 [CI 1.3–3.8])
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Conclusion:  Prehypertension occurs in 30% of Jamaicans and is associated with increased
prevalence of other CVD risk factors. Health-care providers should recognize the increased CVD
risk of prehypertension and should seek to identify and treat modifiable risk factors in these
persons.
Background
The relationship between blood pressure and cardiovas-
cular mortality is thought to be linear with no definite
lower threshold that identifies potential danger or cessa-
tion of benefit [1,2]. Recent studies have documented an
increase in the risk of cardiovascular disease and a high
rate of progression to hypertension in persons with systo-
lic blood pressures between 120 to 139 mmHg and/or
diastolic blood pressures between 80 and 89 mmHg [2-4].
In addition, there have been reported associations
between borderline hypertension (systolic 130–140 mm
Hg or diastolic 85–89 mm Hg) and high normal blood
pressure (systolic 130–139 mmHg or diastolic 85–89
mmHg) with several risk markers for cardiovascular
events, such as increased carotid intima-media thickness,
left ventricular hypertrophy and microalbuminuria [5-8].
Based on the current evidence, the Seventh Report of the
Joint National Committee on Prevention, Detection, Eval-
uation, and Treatment of High Blood Pressure (JNC 7) [9]
recommended a new classification for blood pressure in
which normal blood pressure is defined as systolic blood
pressure < 120 mmHg and diastolic blood pressure of <
80 mmHg, while persons with systolic blood pressure of
120 to139 mmHg and/or diastolic blood pressure of 80 to
89 mmHg are classified as having prehypertension. This
new classification places a large number of persons previ-
ously considered as normal in this higher risk category
and emphasizes the need for monitoring and possible
intervention in persons with blood pressures between the
range of normal and hypertensive.
Since the publication of JNC 7 a number of studies have
reported associations between prehypertension and other
risk factors for cardiovascular disease. These include obes-
ity, high total cholesterol, diabetes mellitus [10], elevated
C-reactive protein [11,12] and left ventricular hypertro-
phy [13]. One study reported an association between pre-
hypertension and coronary atherosclerosis in persons
undergoing coronary angiograms [14]. Little is known
about the association between these risk factors and pre-
hypertension in Jamaica.
To date, there are only a few reports of national prevalence
estimates for prehypertension, with estimates ranging
from 30% to 48.9% [15-19]. In most of theses studies,
prehypertension was more common than hypertension.
The prevalence of prehypertension in Jamaica is not
known. However, hypertension is known to be common
in Jamaica and other developing countries of the Carib-
bean region. Population-based studies have shown a prev-
alence of hypertension of approximately 20% in persons
15–74 years old in Jamaica [20].
The aim of this study was to estimate the prevalence of
prehypertension from a population-based study – The
Jamaica Lifestyle Survey [21]. In order to assess overall car-
diovascular risk, we also examined the association
between prehypertension and some known risk factors for
cardiovascular disease, specifically diabetes mellitus, over-
weight or obesity, high-risk waist circumference and
hypercholesterolaemia.
Methods
The Jamaica Healthy Lifestyle Survey 2000–2001 studied
2012 persons between the ages of 15 and 74 years in order
to estimate the prevalence of hypertension, diabetes and
obesity in Jamaica. The details of the study design and
conduct have been previously published [21]. Participants
were asked to complete an interviewer-administered ques-
tionnaire and had anthropometric and blood pressure
measurements performed by trained observers using
standardized procedures. Fasting blood glucose and total
cholesterol were measured using a capillary blood sample.
Blood pressure was measured from the right arm of the
seated participant after five minutes rest and was recorded
to the nearest 2 mmHg using 1st and 5th Korotkoff
sounds. Three blood pressure measurements were taken
and the mean of the last two measurements was used in
the analysis. Height was measured with a portable stadi-
ometer and recorded to the closest 0.1 cm. Waist circum-
ference and hip circumference were measured with a non-
stretchable tape measure to the nearest 0.1 cm. Weight
was measured with an electronic digital scale to the near-
est 0.1 kg. Measurements were conducted by trained per-
sonnel and all instruments were calibrated once weekly.
Fasting blood glucose and total cholesterol were meas-
ured after a 10 hour overnight fast using a capillary blood
sample analyzed with the Accutrend GCT Roche Diagnos-
tics GmbH instrument.
The protocol for the study was reviewed and approved by
Ethics Committees in the Faculty of Medical Sciences of
the University of the West Indies, Mona and in the Minis-
try of Health, Jamaica.BMC Cardiovascular Disorders 2008, 8:20 http://www.biomedcentral.com/1471-2261/8/20
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Definitions
Prehypertension was defined according to JNC 7 criteria
as having either a systolic blood pressure of 120 to139
mmHg and/or diastolic blood pressure of 80 to 89 mmHg
in persons who were not on treatment for hypertension.
Hypertension was also defined according to JNC 7 criteria
as having an untreated systolic blood pressure (BP) of
greater than or equal to 140 mmHg or diastolic BP greater
than or equal to 90 mmHg or being on medication for
hypertension. Normal blood pressure was defined as hav-
ing both a systolic BP of < 120 mmHg and a diastolic BP
of < 80 mmHg in the absence of antihypertensive medica-
tion. Diabetes mellitus was defined as having a fasting
glucose of greater than or equal to 6.1 mmol/L or being on
treatment for diabetes [22]. Body mass index (BMI) was
calculated as weight in kilograms divided by the square of
the height in metres. Overweight was defined as a BMI
greater than or equal to 25 kg/m2, while obesity was
defined as BMI greater than or equal 30 kg/m2 [23].
Increased (high-risk) waist circumference was defined as
recommended by Lean et al. [24], as greater than 94 cm in
men and greater than 80 cm in women. Increased waist to
hip ratio was defined as greater than or equal to 0.95 for
males and greater than or equal to 0.80 for females.
Hypercholesterolaemia was defined as fasting total serum
cholesterol of greater than or equal to 5.2 mmol/L (200
mg/dL). Cigarette smoking was defined as smoking one or
more cigarettes per day.
Physical activity status defined using information
obtained from the questionnaire. Low activity persons
was defined as infrequent (< 3 times per week) involve-
ment in energy expenditure at either work, traveling to
work or leisure-time activities.
Statistical Methods
Data analysis was carried out using Stata Version 9 [25].
Analysis was restricted to 1972 participants with blood
pressure data. Individual weights were created to correct
for discrepancies between the age-sex distribution of the
sample and that of the Jamaican population of 15–74
year-olds [21]. Standard error estimates for population
prevalence were adjusted to account for the multistage
sampling design used in this study. The chi-squared statis-
tic corrected for survey design determined evidence of sta-
tistically significant association between cardiovascular
risk factors and blood pressure categories. The chi-squared
test for trend identified statistically significant trends in
prevalence of cardiovascular risk factors across ordinal
blood pressure categories. Multivariate logistic regression
analysis provided estimates of the odds of prehyperten-
sive participants having given CVD risk factors as well as
various clusters of risk factors, namely, central obesity
(having a high-risk waist circumference), smoking ciga-
rettes, having diabetes mellitus, having high cholesterol or
being older than forty five years. Separate models were
created for each cardiovascular risk factor. Each model
estimated the relative increase in the odds of having the
respective risk factor for prehypertensive persons com-
pared with normotensive persons. Odds ratios from mod-
els with hypercholesterolaemia or diabetes as outcome
variable were adjusted for age, sex and overweight status.
Odds ratios from models with measures of obesity as the
outcome variable were adjusted for age, sex, diabetes and
hypercholesterolaemia. We report age-group specific esti-
mates of these odds ratios from models that gave statisti-
cally significant evidence of an interaction of age with
prehypertension.
To examine the clustering of risk factors for cardiovascular
disease, we estimated the proportion of participants
within blood pressure categories having one, two or three
or more of the five aforementioned additional risk factors.
We then used logistic regression models to calculate sex-
specific, age adjusted odds ratios for having one, two, or
three or more additional risk factors among prehyperten-
sive participants compared to those with normal blood
pressure.
Results
Of the 1972 participants included in the analyses 661
(33.5%) were males and 1311 (66.5%) were females. The
mean age was 36.3 ± 0.45 years with no sex difference.
Selected characteristics of participants in the survey
grouped according to blood pressure categories are shown
in Table 1. With the exception of height, the mean values
for the characteristics presented were significantly higher
(p < 0.001) among the prehypertensive and hypertensive
groups compared to those with normal blood pressure.
There was also a statistically significant trend (p < 0.001)
for higher means of all characteristics, except height, going
from normal blood pressure to hypertension. Compari-
son of the mean values for the other variables of interest
between those who were excluded because of a missing
value and those included, revealed no differences except
for age, where those with any missing values were younger
than those with no missing values (37.7 vs. 41.3, p =
0.003).
The overall prevalence of prehypertension among Jamai-
cans 15–74 years old was found to be 30% (95% confi-
dence interval [CI] 27%–33%). Prehypertension was
more common in men than women, 35% (CI 31%–39%)
and 25% (CI 22%–28%) respectively (p < 0.001 for male-
female difference in proportion). Age and sex specific
prevalence estimates are shown Figure 1. Prehypertension
was more common in men than women at all ages except
in the 65–74 year old age group. Among men, prehyper-
tension prevalence ranged between 35–39% for the
15–64 year-old age groups then fell to 20% among thoseBMC Cardiovascular Disorders 2008, 8:20 http://www.biomedcentral.com/1471-2261/8/20
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aged 65–74 years old (p for trend 0.04). Among women
however, prehypertension prevalence was low at 18%
among the youngest age group, and increased with age up
to the 45–54 year-old age group, where the prevalence was
31%, after which there was a decline in the older age
groups, 23% and 22% in the 55–64 year-old and 65–74
year-old age groups respectively (the test for trend was not
significant).
Table 2 shows the crude and sex-specific prevalence of car-
diovascular risk factors among participants in the study.
Overall there was high prevalence of obesity in the study
population. Almost 46% of participants were overweight
(≥ 25 kg/m2); 19.7% were obese (≥ 30 kg/m2); 30.5% had
increased waist/hip ratio while 36% had increased waist
circumference. The prevalence low physical activity levels
was estimated at 36.3%. Prevalence estimates were lower
for other CVD risk factors: 14.6% for hypercholestero-
lemia, 7.2% for diabetes mellitus and 17.8% for cigarette
smoking. There were marked sex differences in the preva-
lence of CVD risk factors except for diabetes mellitus. For
measures of obesity, prevalence was two to nine times
higher among women compared to men (p < 0.001 for all
measures).
Age-group and sex specific prevalence of prehypertension (with 95% confidence intervals shown as error bars) in the Jamaica  Lifestyle Survey 2000–2001 Figure 1
Age-group and sex specific prevalence of prehypertension (with 95% confidence intervals shown as error bars) in the Jamaica 
Lifestyle Survey 2000–2001.
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Table 1: Means and standard error for selected characteristics of participants in the Jamaica Lifestyle Survey 2000–2001 within and 
across blood pressure categories.
Total 
N = 1972
Normotensive* 
N = 875
Prehypertensive 
N = 555
Hypertensive 
N = 542
p-value for association**
Characteristics N Mean ± SE# Mean ± SE Mean ± SE Mean ± SE
Age (years) 1953 36.3 ± 0.45 30.3 ± 0.44 36.6 ± 0.73 50.2 ± 0.83 < 0.001
Weight (kg) 1939 71.5 ± 0.47 67.5 ± 0.55 74.0 ± 0.75 77.5 ± 1.01 < 0.001
Height (cm) 1936 167.1 ± 0.33 166.6 ± 0.39 168.6 ± 0.56 166.2 ± 0.54 0.002
Waist circumference (cm) 1944 82.3 ± 0.41 77.9 ± 0.48 84.1 ± 0.64 90.3 ± 0.86 < 0.001
Hip Circumference (cm) 1935 99.7 ± 0.46 97.1 ± 0.53 101.3 ± 0.62 103.8 ± 0.73 < 0.001
Waist to Hip Ratio 1932 0.82 ± 0.003 0.82 ± 0.003 0.83 ± 0.003 0.86 ± 0.005 < 0.001
Body mass index (kg/m2) 1930 25.7 ± 0.18 24.4 ± 0.22 26.1 ± 0.28 28.1 ± 0.38 < 0.001
Cholesterol level (mmol/L) 1848 4.5 ± 0.02 4.3 ± 0.2 4.5 ± 0.46 4.8 ± 0.06 < 0.001
Fasting Glucose (mmol/L) 1881 4.3 ± 0.05 4.0 ± 0.04 4.21 ± 0.07 5.0 ± 0.12 < 0.001
* Normotensive: blood pressure (BP) < 120/80 mmHg; Prehypertensive: BP = 120–139/80–89 mmHg and not on anti-hypertensive medication; 
Hypertensive: BP ≥ 140/90 or on anti-hypertensive medication
** Apart from height all characteristics showed a statistically significant increasing trend (P < 0.001) going from normotensive to hypertensive
#SE = Standard errorBMC Cardiovascular Disorders 2008, 8:20 http://www.biomedcentral.com/1471-2261/8/20
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Table 3 shows the sex-specific prevalence of CVD risk fac-
tors and risk factor clusters by blood pressure categories
with assessment for trends moving from normal to high
blood pressure. With the exception of cigarette smoking
and low physical activity levels all the CVD risk factors
studied had significantly higher prevalence in the prehy-
pertensive and hypertensive groups compared to the nor-
motensive group among both men and women. There
were also statistically significant trends (p < 0.001) for
higher prevalence going from normal to high blood pres-
sure. Low physical activity was also associated with blood
pressure among men with higher prevalence among those
with prehypertension or hypertension. Among women
however, the prevalence of low physical activity was high
in all blood pressure categories. For cigarette smoking,
persons with hypertension had lower prevalence of ciga-
rette smoking compared to those with normal blood pres-
sure or prehypertension among both men and women.
The proportion of persons with clustering of CVD risk fac-
tors are also shown in Table 3. They are grouped as "no
additional risk factor", "one additional risk factor", "two
additional risk factors" and three or more additional risk
factors"; and reported as sex-specific estimates by blood
pressure category. Compared with normotensive men,
those with prehypertension were more likely to have two
additional risk factors (19.6% among prehypertensive vs.
11.0% among normotensive), or three or more additional
risk factors (6.8% among prehypertensive vs. 1.8% among
normotensive persons). Similarly, among women, a
higher proportion of those with prehypertension had one,
two and three or more risk factors compared to those with
normal blood pressure. Almost 41% of prehypertensive
women had one additional risk factor, 25.8% had two
additional risk factors, and 10.6% had three or more risk
factors, compared to 33.6%, 13.8% and 4.2% for the
respective groups with normal blood pressure.
In order to estimate the relative risk for the presence of
CVD risk factors among person with prehypertension
compared to those with normal blood pressure, odds
ratios were obtained using logistic regression models with
adjustments for age and sex and other CVD risk factors as
stated above. These odds ratios are shown in Table 4.
There was significant effect modification with age and
therefore age-group specific odds ratios were calculated.
There was no significant association for the odds of diabe-
tes mellitus among prehypertensive persons in any age
group. Odds of obesity, overweight, high cholesterol and
increased waist circumference tended to be significantly
higher among young persons (15–44 year olds) with pre-
hypertension compared to young persons with normal
blood pressure. The odds ratio for increased waist/hip
ratio was only significant among younger prehypertensive
persons in the age group 15–24 years. In the older age
groups (45 year olds and older), while the odds of the
CVD risk factors were often higher among those with pre-
hypertension the association was not significant except for
increased waist/hip ratio in the 45–54 year-old age group.
We also estimated the age-adjusted odds ratio for relative
increase in odds for one, two, and three or more risk fac-
tors compared to having no risk factors for male and
female prehypertensive participants compared to normo-
tensive participants. Among men, being prehypertensive
is associated with an almost three-fold (OR 2.8 [CI
1.1–7.2]) increase in the odds of having three or more risk
factors, while there is no apparent increased odds associ-
ated with two (OR 1.4 [0.7–2.9]) or one (OR 0.8
[0.5–1.4]) CVD risk factors. Among women, being prehy-
pertensive is associated with increased odds at all levels of
other CVD risk factors, with an approximately two-fold
increase in the odds at each level of risk. The odds ratio for
having three or more risk factors was 2.0 (95%CI 1.3–3.0)
Table 2: Crude and sex-specific prevalence of cardiovascular disease risk factors in the Jamaica Lifestyle Survey 2000–2001.
Characteristics Male 
(N = 661)
Female 
(N = 1311)
Total 
(N = 1972)
% (95% CI) % (95% CI) % (95% CI)
Obesity** (BMI ≥ 30 kg/m2) 9.0 (6.8–11.3) 30.0 (26.8–33.2) 19.7 (17.4–22.0)
Overweight** (BMI ≥ 25 kg/m2) 30.2 (25.7–34.6) 60.7(57.4–64.0) 45.7 (42.6–48.9)
Increased Waist Circumference** 14.6 (11.6–17.6) 56.7 (53.2–60.2) 36.0 (33.0–39.0)
Increased Waist/Hip ratio** 6.1 (4.0–8.1) 54.4 (50.6–58.2) 30.5 (27.9–33.2)
Hypercholesterolaemia* 11.6 (8.8–14.5) 17.4 (15.1–19.8) 14.6 (12.7–16.5)
Diabetes Mellitus 6.3 (4.3–8.3) 8.0 (6.6–9.4) 7.2 (6.0–8.3)
1Cigarette Smoking** 28.3 (24.1–32.5) 7.3 (5.6–8.9) 17.6 (15.2–20.1)
Low Physical activity** 21.3 (17.3–25.4) 50.9 (46.8–54.9) 36.3 (33.0–39.7)
1 Currently smokes cigarettes regardless of quantity per day.
* P < 0.01 (male – female difference in proportions)
** P < 0.001 (male – female difference in proportions)BMC Cardiovascular Disorders 2008, 8:20 http://www.biomedcentral.com/1471-2261/8/20
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while for two risk factors, the odds ratio was 2.3 (1.3–3.8)
and for one risk factor, the odds ratio was 2.3 (1.4–4.0).
Discussion
The results of this study indicate that prehypertension
affects almost one third of the Jamaican population. In
this study the prevalence was higher in males compared to
females in all age categories up to age 64 years and was
similar in men and women in the oldest age category. Pre-
hypertension was associated with several other risk factors
for cardiovascular disease with significantly higher preva-
lence of overweight, obesity, increased waist circumfer-
ence, hypercholesterolemia and diabetes mellitus when
compared to persons with normal blood pressure. In
addition, persons with prehypertension were more likely
to have multiple additional CVD risk factors when com-
pared to those with normal blood pressure.
The findings in our study are generally consistent with
other studies in the published literature. Prevalence esti-
mates reported range from 31% in the United States,
31.6% in Korea, 34% in Taiwan, 40% in the Ashanti
region of Ghana, to 47% in Liaoning Province in China
and 48.9% among the military in Israel [15-19,26]. Except
Table 3: Prevalence of individual cardiovascular disease risk factors and risk factor clusters by sex and blood pressure categories in the 
Jamaica Lifestyle Survey 2000–2001.
Individual Cardiovascular Disease Risk Factor
Male Female
Normal BP
%
(95% CI)
Pre-HTN
%
(95% CI)
HTN
%
(95% CI)
P-value
(trend)
Normal BP
%
(95% CI)
Pre-HTN
%
(95% CI)
HTN
%
(95% CI)
P-value
(trend)
Obesity 4.8
(2.0–7.5)
8.6
(4.9–12.4)
19.5
(11.8–27.1)
< 0.001 19.7
(16.6–22.8)
39.0
(32.7–45.2)
45.4
(39.6–51.3)
< 0.001
Overweight 19.2
(14.4–24.0)
31.2
(24.9–37.5)
53.3
(43.3–63.4)
< 0.001 48.4
(44.1–52.8)
71.3
(65.8–76.9)
79.1
(75.2–83.3)
< 0.001
Increased
Waist
Circumference
6.3
(3.2–9.4)
13.7
(8.7–18.6)
34.6
(26.3–43.0)
< 0.001 42.4
(37.9–46.8)
66.9
(60.8–72.9)
81.1
(77.1–85.1)
< 0.001
Increased
Waist/Hip
ratio
2.6
(0.4–4.9)
4.7
(2.0–7.6)
16.2
(9.4–23.1)
< 0.001 42.1
(37.2–47.0)
60.4
(54.6–66.2)
78.1
(72.6–83.5)
< 0.001
Hypercholesterolaemia 5.6
(2.6–8.7)
13.7
(8.6–18.6)
21.4
(14.3–28.4)
< 0.001 11.4
(8.9–13.9)
21.5
(16.5–26.5)
27.7
(22.7–32.6)
< 0.001
Diabetes
Mellitus
2.2
(0.6–3.8)
4.3
(1.9–6.6)
19.0
(12.1–25.9)
< 0.001 2.4
(1.3–3.5)
7.2
(4.8–9.5)
22.4 
(17.5–27.2)
< 0.001
1Cigarette
Smoking
31.7
(24.6–38.8)
28.8
(21.6–35.9)
19.8
(14.2–25.4)
0.004 8.0
(5.7–10.3)
6.8
(3.7–10.0)
5.9
(3.2–8.5)
0.033
Low Physical
Activity
18.7
(13.1–24.3)
20.8
(14.1–27.4)
28.3
(20.4–36.2)
0.007 52.0
(47.2–56.9)
46.2
(39.8–52.7)
53.4
(46.2–60.6)
0.181
Risk Factor Clustering2
Male Female
Normal BP
%
(95% CI)
Pre-HTN
%
(95% CI)
HTN
%
(95% CI)
P-value
(trend)
Normal BP
%
(95% CI)
Pre-HTN
%
(95% CI)
HTN
%
(95% CI)
P-value
(trend)
No Additional
Risk Factor
54.1
(47.9–60.3)
45.6
(37.1–54.1)
19.6
(10.5–28.7)
< 0.001 48.4
(43.9–52.8)
22.6
(16.2–29.2)
6.7
(3.6–9.7)
< 0.001
1 Additional
Risk Factor
33.1
(26.5–39.6)
28.0
(21.9–34.1)
29.1
(20.5–37.7)
0.225 33.6
(29.3–37.9)
40.9
(35.3–46.5)
26.1
(20.6–31.5)
< 0.001
2 Additional
Risk Factors
11.0
(6.8–15.2)
19.6
(13.6–25.5)
30.4
(23.8–37.1)
< 0.001 13.8
(10.9–16.7)
25.8
(20.5–31.2)
32.9
(27.1–38.7)
< 0.001
≥3 Additional
Risk Factors
1.8
(0.4–3.2)
6.8
(3.5–10.2)
20.9
(15.0–26.7)
< 0.001 4.2
(2.4–6.1)
10.6
(7.6–13.5)
34.3
(28.8–39.8)
< 0.001
1 Currently smokes cigarettes regardless of quantity per day
2 Risk factors include diabetes mellitus, hypercholesterolemia, central obesity, cigarette smoking and age > 45 yearsBMC Cardiovascular Disorders 2008, 8:20 http://www.biomedcentral.com/1471-2261/8/20
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for the 48.9% in Israel and the 47% from Liaoning Prov-
ince in China these figures are generally similar to our esti-
mates for Jamaica. The prevalence of prehypertension is
therefore high in both developed and developing coun-
tries and in eastern and western populations. This sup-
ports the view that the rates of chronic non-
communicable diseases, in particular cardiovascular dis-
eases, in developing countries are rapidly approaching the
rates in developed countries and that their prevention
requires urgent attention [27].
The association of prehypertension with multiple risk fac-
tors for cardiovascular disease has also been described in
the American population where the odds of hypercholes-
terolemia, diabetes mellitus and overweight/obesity was
found to be greater among persons with prehypertension
compared to persons who were normotensive [10]. In
Korea, persons with prehypertension were more likely to
have the metabolic syndrome than persons who had nor-
mal blood pressure [15]. In addition the study from Israel
found that both men and women with prehypertension
were more likely to have hyperglycemia, dyslipidaemia,
obesity, the metabolic syndrome and a > 15% ten year risk
of CVD when compared to persons with normal blood
pressure [16]. This clustering of cardiovascular disease risk
factors among persons with prehypertension suggest that
persons found to have prehypertension should be
screened for other cardiovascular disease risk factors,
regardless of age.
The higher prevalence of prehypertension among men
(particularly younger men) compared to women is note-
worthy. This finding of higher blood pressures among
younger men compared to women has been previously
reported in the Caribbean [28]. Overall, the high preva-
lence of prehypertension in the younger age groups sug-
gest that although the absolute risk of CVD attributable to
prehypertension may be low, the population attributable
risk may be relatively high and therefore will have impor-
tant public health implications.
Based on data from The Statistical Institute of Jamaica
[29] the thirty percent prevalence of prehypertension rep-
resents approximately seven hundred and eighty thou-
sand persons in Jamaica in this age range. Prior to the
publication of JNC 7 these persons would have been con-
sidered to have "normal" blood pressure and may not
have been recognized as potential candidates for cardio-
vascular intervention or risk reduction. We now know
however, that persons with prehypertension are at
increased risk of cardiovascular events including progres-
sion to hypertension. The evidence that these persons are
at risk is now quite convincing and some studies have
begun to evaluate the role of pharmacological interven-
tion [30]. The need for intervention, whether lifestyle or
pharmacological is supported by the findings of Russell et
al. who estimated that among adults 25–74 years old in
the United States, prehypertension alone accounted for
3.4% of hospitalizations, 6.5% of nursing home admis-
sions and 9.1% of deaths [31]. These data suggest that pre-
hypertension should probably be included in the various
instruments for estimating cardiovascular risk among per-
sons in the lower risk groups.
The public health implication of this increased burden of
at-risk people in our population is worthy of serious eval-
uation. It has been estimated that a 5 mmHg reduction in
systolic blood pressure in the population will produce a
14% reduction in the risk of stroke and a 9% reduction in
the risk of coronary heart disease [9]. If we apply a popu-
lation approach to disease prevention we could therefore
expect that a small reduction in mean population blood
pressure will result in relatively large reductions in overall
CVD risk. This can be achieved through either lifestyle or
pharmacological intervention. It is unlikely that develop-
ing countries can afford pharmacological intervention
[30] and lifestyle intervention [9,32,33] may be difficult
Table 4: Age specific odds ratios (with 95% CI in brackets) from multivariate logistic regression models for cardiovascular disease risk 
factors among prehypertensive persons compared to normotensive persons in the Jamaica Lifestyle Survey.
Age Group (years)
Risk Factor 15–24 25–34 35–44 45–54 55–64 65 & older
Obese+ 3.2(1.7–5.9) 1.7(1.01–2.8) 2.8(1.8–4.3) 1.8(0.8–3.9) 1.1(0.5–2.5) 0.9(0.2–3.5)
Overweight+ 2.8(1.6–4.7) 2.2(1.3–3.6) 1.4(0.9–2.3) 1.3(0.6–2.8) 1.0(0.4–2.6) 1.1(0.3–3.5)
High cholesterol++ 1.5(0.5–4.4) 2.0(1.1–3.7) 1.9(1.1–3.4) 2.1(0.8–5.2) 0.5(0.2–1.3) 0.8(0.3–1.9)
Diabetes++ 0.7 (0.2–2.7)+++ 0.7(0.2–2.7) 1.8(0.7–5.0) 2.4 (0.8–7.9) 4.1(0.8–19.8)
Increased Waist circumference+ 3.1 (1.6–5.9) 2.0(1.1–3.3) 1.4(0.9–2.2) 1.6(0.8–3.3) 1.6(0.5–4.7) 1.6(0.4–5.7)
Increased+ Waist/Hip ratio 1.9(1.1–3.2) 1.3(0.9–2.0) 1.03(0.6–1.8) 3.1(1.3–7.3) 1.01(0.5–2.2) 0.8(0.3–2.8)
+ Odds ratios adjusted for sex, diabetes and high cholesterol status
++ Odds ratios adjusted for sex and overweight status
+++ Odds ratios for age range 15–34 since there were no diabetes cases in the 15–24 year-olds.BMC Cardiovascular Disorders 2008, 8:20 http://www.biomedcentral.com/1471-2261/8/20
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to implement and maintain. Any intervention strategy
will therefore require a multi-level, multi-sectorial
approach [34-36].
The cross-sectional design of our study prohibits any
causal inference from the identified associations as a time-
sequence relationship cannot be determined. The study
was population based and the sample was selected to be
representative of the general Jamaican population. Where
particular segments were not adequately represented
weights were added to correct this prior to statistical anal-
ysis. One other possible limitation of this study is that
there were missing data for some variables used in the
analysis. The proportion of missing variables was however
relatively small ranging from 3–8%. In addition there
were no significant differences in the mean values of
demographic and available CVD characteristics, except for
age, for those with any missing data compared to those
with no missing data. We are therefore satisfied that the
estimates presented reflect the situation in the general
Jamaican population. Given the similarities between the
Jamaican population and other countries of the English
speaking Caribbean, it is likely that these findings are
applicable to the other countries of the Caribbean region.
Conclusion
Prehypertension is highly prevalent in Jamaica and clus-
ters with other cardiovascular disease risk factors. Health
care providers and health planners should be made aware
of the large numbers of persons at increased risk for cardi-
ovascular disease and steps should be taken to identify
and treat modifiable risk factors in such persons. At the
very least a proper diet and regular exercise should be rec-
ommended. Further studies are needed to determine the
rate of cardiovascular events in the prehypertensive popu-
lation and the impact of various interventions on the rates
of these cardiovascular events.
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